Social anxiety disorder clinical course and outcome: review of Harvard/Brown Anxiety Research Project (HARP) findings.
Preliminary findings from a long-term, prospective, longitudinal, naturalistic treatment study of adults with social anxiety disorder (SAD) demonstrate that this illness has a chronic course and a greater adverse impact on social functioning than do depressive symptoms or chronic medical illnesses. Comorbid anxiety, depressive, and personality disorders are common in patients with SAD. Only 35% of patients with SAD recovered after 10 years of prospective follow-up. Whereas, the relapse rate, once recovery is achieved, is 34% during this 10-year follow-up. Treatment is underutilized in patients with SAD, and a long-term treatment approach may be needed to improve the likelihood of recovery from SAD.
Keller
Martin B
MB
Department of Psychiatry & Human Behavior, Brown University School of Medicine, Providence, RI 02912, USA. martin_keller@brown.edu
D000328:Adult; D002908:Chronic Disease; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D017063:Outcome Assessment, Health Care; D010554:Personality Disorders / Q000175:diagnosis / Q000453:epidemiology; D010698:Phobic Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D015995:Prevalence; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012008:Recurrence; D016896:Treatment Outcome
D011619:Psychotropic Drugs